Diamyd Medical AB (DMYDb)

Currency in SEK
11.160
0.000(0.00%)
Real-time Data·
DMYDb Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
DMYDb is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
11.16011.480
52 wk Range
7.50019.500
Key Statistics
Prev. Close
11.16
Open
11.16
Day's Range
11.16-11.48
52 wk Range
7.5-19.5
Volume
63.34K
Average Volume (3m)
470.29K
1-Year Change
-40%
Book Value / Share
2.36
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DMYDb Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Diamyd Medical AB News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Diamyd Medical AB Company Profile

Diamyd Medical AB (publ) develops precision medicine therapies for the treatment of autoimmune diabetes. The company develops Diamyd, an antigen-specific immunotherapy, which is in phase III clinical trial for the treatment of type 1 diabetes and latent autoimmune diabetes in adults (LADA); and Remygen, an immunomodulation therapy, that is in phase I/II clinical trial for the treatment of with type 1 diabetes, type 2 diabetes, and LADA. It has a research and development collaboration agreement with Juvenile Diabetes Research Foundation to develop DIAGNODE-3 Phase 3 trial in type 1 diabetes. The company was formerly known as Diamyd Therapeutics AB and changed its name to Diamyd Medical AB (publ) in April 2013. Diamyd Medical AB (publ) was founded in 1984 and is headquartered in Stockholm, Sweden.

Compare DMYDb to Peers and Sector

Metrics to compare
DMYDb
Peers
Sector
Relationship
P/E Ratio
−8.7x−11.6x−0.6x
PEG Ratio
0.900.710.00
Price/Book
4.7x7.4x2.6x
Price / LTM Sales
11,767.4x7,825.9x3.3x
Upside (Analyst Target)
65.8%12.3%39.1%
Fair Value Upside
Unlock3.3%4.5%Unlock

Earnings

Latest Release
Jun 25, 2025
EPS / Forecast
-0.41 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

DMYDb Income Statement

FAQ

What Stock Exchange Does Diamyd Medical Trade On?

Diamyd Medical is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Diamyd Medical?

The stock symbol for Diamyd Medical is "DMYDb."

What Is the Diamyd Medical Market Cap?

As of today, Diamyd Medical market cap is 1.54B.

What Is Diamyd Medical's Earnings Per Share (TTM)?

The Diamyd Medical EPS (TTM) is -1.70.

When Is the Next Diamyd Medical Earnings Date?

Diamyd Medical will release its next earnings report on 07 Oct 2025.

From a Technical Analysis Perspective, Is DMYDb a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Diamyd Medical Stock Split?

Diamyd Medical has split 2 times.

How Many Employees Does Diamyd Medical Have?

Diamyd Medical has 30 employees.

What is the current trading status of Diamyd Medical (DMYDb)?

As of 19 Aug 2025, Diamyd Medical (DMYDb) is trading at a price of 11.16, with a previous close of 11.16. The stock has fluctuated within a day range of 11.16 to 11.48, while its 52-week range spans from 7.50 to 19.50.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.